List of Excipients in API CYCLOPHOSPHAMIDE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing CYCLOPHOSPHAMIDE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Hikma Pharmaceuticals USA Inc | CYCLOPHOSPHAMIDE | cyclophosphamide | 0054-0382 | AMMONIA | |
| Hikma Pharmaceuticals USA Inc | CYCLOPHOSPHAMIDE | cyclophosphamide | 0054-0382 | BUTYL ALCOHOL | |
| Hikma Pharmaceuticals USA Inc | CYCLOPHOSPHAMIDE | cyclophosphamide | 0054-0382 | FD&C BLUE NO. 1 | |
| Hikma Pharmaceuticals USA Inc | CYCLOPHOSPHAMIDE | cyclophosphamide | 0054-0382 | FD&C RED NO. 40 | |
| Hikma Pharmaceuticals USA Inc | CYCLOPHOSPHAMIDE | cyclophosphamide | 0054-0382 | FERROSOFERRIC OXIDE | |
| Hikma Pharmaceuticals USA Inc | CYCLOPHOSPHAMIDE | cyclophosphamide | 0054-0382 | GELATIN | |
| Hikma Pharmaceuticals USA Inc | CYCLOPHOSPHAMIDE | cyclophosphamide | 0054-0382 | ISOPROPYL ALCOHOL | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing CYCLOPHOSPHAMIDE
Detailed excipient profiles for CYCLOPHOSPHAMIDE
Excipient focus: ACACIA
CYCLOPHOSPHAMIDE drug variants containing ACACIA
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | cyclophosphamide | 54868-5218 |
| >Company | >Ingredient | >NDC |
CYCLOPHOSPHAMIDE drug variants not containing ACACIA
Excipient focus: ALCOHOL
CYCLOPHOSPHAMIDE drug variants containing ALCOHOL
CYCLOPHOSPHAMIDE drug variants not containing ALCOHOL
Excipient focus: AMMONIA
CYCLOPHOSPHAMIDE drug variants containing AMMONIA
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | cyclophosphamide | 0054-0382 |
| STI Pharma LLC | cyclophosphamide | 54879-022 |
| Cipla USA Inc | cyclophosphamide | 69097-516 |
| >Company | >Ingredient | >NDC |
CYCLOPHOSPHAMIDE drug variants not containing AMMONIA
Excipient focus: ANHYDROUS CITRIC ACID
CYCLOPHOSPHAMIDE drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Eugia US LLC | cyclophosphamide | 55150-270 |
| >Company | >Ingredient | >NDC |
CYCLOPHOSPHAMIDE drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: BUTYL ALCOHOL
CYCLOPHOSPHAMIDE drug variants containing BUTYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | cyclophosphamide | 0054-0382 |
| ANI Pharmaceuticals Inc | cyclophosphamide | 43975-308 |
| STI Pharma LLC | cyclophosphamide | 54879-022 |
| ANI Pharmaceuticals Inc | cyclophosphamide | 62559-930 |
| Cipla USA Inc | cyclophosphamide | 69097-516 |
| >Company | >Ingredient | >NDC |
CYCLOPHOSPHAMIDE drug variants not containing BUTYL ALCOHOL
Excipient focus: CELLULOSE, MICROCRYSTALLINE
CYCLOPHOSPHAMIDE drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | cyclophosphamide | 54868-5218 |
| >Company | >Ingredient | >NDC |
CYCLOPHOSPHAMIDE drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: D&C YELLOW NO. 10
CYCLOPHOSPHAMIDE drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | cyclophosphamide | 43975-308 |
| ANI Pharmaceuticals Inc | cyclophosphamide | 62559-930 |
| >Company | >Ingredient | >NDC |
CYCLOPHOSPHAMIDE drug variants not containing D&C YELLOW NO. 10
Excipient focus: DEHYDRATED ALCOHOL
CYCLOPHOSPHAMIDE drug variants containing DEHYDRATED ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddy's Laboratories Inc | cyclophosphamide | 43598-660 |
| Avyxa Pharma LLC | cyclophosphamide | 83831-116 |
| >Company | >Ingredient | >NDC |
CYCLOPHOSPHAMIDE drug variants not containing DEHYDRATED ALCOHOL
Excipient focus: FD&C BLUE NO. 1
CYCLOPHOSPHAMIDE drug variants containing FD&C BLUE NO. 1
CYCLOPHOSPHAMIDE drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 2
CYCLOPHOSPHAMIDE drug variants containing FD&C BLUE NO. 2
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | cyclophosphamide | 43975-308 |
| ANI Pharmaceuticals Inc | cyclophosphamide | 62559-930 |
| >Company | >Ingredient | >NDC |
CYCLOPHOSPHAMIDE drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C GREEN NO. 3
CYCLOPHOSPHAMIDE drug variants containing FD&C GREEN NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | cyclophosphamide | 43975-308 |
| ANI Pharmaceuticals Inc | cyclophosphamide | 62559-930 |
| >Company | >Ingredient | >NDC |
CYCLOPHOSPHAMIDE drug variants not containing FD&C GREEN NO. 3
Excipient focus: FD&C RED NO. 3
CYCLOPHOSPHAMIDE drug variants containing FD&C RED NO. 3
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | cyclophosphamide | 46708-618 |
| STI Pharma LLC | cyclophosphamide | 54879-022 |
| Alembic Pharmaceuticals Inc | cyclophosphamide | 62332-618 |
| Cipla USA Inc | cyclophosphamide | 69097-516 |
| >Company | >Ingredient | >NDC |
CYCLOPHOSPHAMIDE drug variants not containing FD&C RED NO. 3
Excipient focus: FD&C RED NO. 40
CYCLOPHOSPHAMIDE drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | cyclophosphamide | 0054-0382 |
| ANI Pharmaceuticals Inc | cyclophosphamide | 43975-308 |
| ANI Pharmaceuticals Inc | cyclophosphamide | 62559-930 |
| >Company | >Ingredient | >NDC |
CYCLOPHOSPHAMIDE drug variants not containing FD&C RED NO. 40
Excipient focus: FERROSOFERRIC OXIDE
CYCLOPHOSPHAMIDE drug variants containing FERROSOFERRIC OXIDE
CYCLOPHOSPHAMIDE drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GELATIN
CYCLOPHOSPHAMIDE drug variants containing GELATIN
CYCLOPHOSPHAMIDE drug variants not containing GELATIN
Excipient focus: ISOPROPYL ALCOHOL
CYCLOPHOSPHAMIDE drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Hikma Pharmaceuticals USA Inc | cyclophosphamide | 0054-0382 |
| ANI Pharmaceuticals Inc | cyclophosphamide | 43975-308 |
| STI Pharma LLC | cyclophosphamide | 54879-022 |
| ANI Pharmaceuticals Inc | cyclophosphamide | 62559-930 |
| Cipla USA Inc | cyclophosphamide | 69097-516 |
| >Company | >Ingredient | >NDC |
CYCLOPHOSPHAMIDE drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LACTOSE MONOHYDRATE
CYCLOPHOSPHAMIDE drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | cyclophosphamide | 54868-5218 |
| >Company | >Ingredient | >NDC |
CYCLOPHOSPHAMIDE drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
CYCLOPHOSPHAMIDE drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | cyclophosphamide | 54868-5218 |
| >Company | >Ingredient | >NDC |
CYCLOPHOSPHAMIDE drug variants not containing MAGNESIUM STEARATE
Excipient focus: MANNITOL
CYCLOPHOSPHAMIDE drug variants containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Sagent Pharmaceuticals | cyclophosphamide | 25021-247 |
| XGen Pharmaceuticals DJB Inc | cyclophosphamide | 39822-0255 |
| >Company | >Ingredient | >NDC |
CYCLOPHOSPHAMIDE drug variants not containing MANNITOL
Excipient focus: METHYL ALCOHOL
CYCLOPHOSPHAMIDE drug variants containing METHYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| ANI Pharmaceuticals Inc | cyclophosphamide | 43975-308 |
| ANI Pharmaceuticals Inc | cyclophosphamide | 62559-930 |
| >Company | >Ingredient | >NDC |
CYCLOPHOSPHAMIDE drug variants not containing METHYL ALCOHOL
Excipient focus: MONOTHIOGLYCEROL
CYCLOPHOSPHAMIDE drug variants containing MONOTHIOGLYCEROL
CYCLOPHOSPHAMIDE drug variants not containing MONOTHIOGLYCEROL
Excipient focus: NITROGEN
CYCLOPHOSPHAMIDE drug variants containing NITROGEN
CYCLOPHOSPHAMIDE drug variants not containing NITROGEN
Excipient focus: POLYETHYLENE GLYCOL 400
CYCLOPHOSPHAMIDE drug variants containing POLYETHYLENE GLYCOL 400
CYCLOPHOSPHAMIDE drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POTASSIUM HYDROXIDE
CYCLOPHOSPHAMIDE drug variants containing POTASSIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Alembic Pharmaceuticals Limited | cyclophosphamide | 46708-618 |
| Alembic Pharmaceuticals Inc | cyclophosphamide | 62332-618 |
| >Company | >Ingredient | >NDC |
CYCLOPHOSPHAMIDE drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: PROPYLENE GLYCOL
CYCLOPHOSPHAMIDE drug variants containing PROPYLENE GLYCOL
CYCLOPHOSPHAMIDE drug variants not containing PROPYLENE GLYCOL
Excipient focus: SHELLAC
CYCLOPHOSPHAMIDE drug variants containing SHELLAC
CYCLOPHOSPHAMIDE drug variants not containing SHELLAC
Excipient focus: SODIUM STEARYL FUMARATE
CYCLOPHOSPHAMIDE drug variants containing SODIUM STEARYL FUMARATE
CYCLOPHOSPHAMIDE drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: STARCH, CORN
CYCLOPHOSPHAMIDE drug variants containing STARCH, CORN
CYCLOPHOSPHAMIDE drug variants not containing STARCH, CORN
Excipient focus: TITANIUM DIOXIDE
CYCLOPHOSPHAMIDE drug variants containing TITANIUM DIOXIDE
CYCLOPHOSPHAMIDE drug variants not containing TITANIUM DIOXIDE
Excipient focus: WATER
CYCLOPHOSPHAMIDE drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Sagent Pharmaceuticals | cyclophosphamide | 25021-247 |
| STI Pharma LLC | cyclophosphamide | 54879-022 |
| >Company | >Ingredient | >NDC |
CYCLOPHOSPHAMIDE drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
